Editorial: New Drug Targets for Proteotoxicity in Cardiometabolic Diseases
Main Authors: | Jun Ren, Xin Wang, Yingmei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.745296/full |
Similar Items
-
Autophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome
by: Mingjie Yang, et al.
Published: (2018-05-01) -
Editorial: Remodeling in cardiometabolic diseases: Towards biomarker characterization, target therapy identification, and drug delivery strategies
by: Hania Ammar, et al.
Published: (2023-03-01) -
Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications
by: Teresa Pasqua, et al.
Published: (2021-02-01) -
The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
by: Chen Li, et al.
Published: (2023-04-01) -
Editorial: RNAs at the crossroads between effectors and targets; discovery and development of new drugs
by: Federica Chiappori, et al.
Published: (2023-02-01)